PDS Biotechnology CorporationPDSBNASDAQ

Revenue (LTM)

Net Income (LTM)

$-38M

+12.4% YoY

Free Cash Flow

$-35M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.0B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	0	0	0	0	0
Gross Profit	0	0	0	-0	-0↓4.3%
Operating Income	-15	-21↓43.9%	-42↓94.4%	-43↓3.3%	-36↑15.6%
Net Income	-15	-17↓13.9%	-41↓141.5%	-43↓5.1%	-38↑12.4%
EBITDA	-15	-21↓44.0%	-41↓90.1%	-40↑1.6%	-34↑15.8%
EPS Diluted	-0.89	-0.66↑25.8%	-1.43↓116.7%	-1.39↑2.8%	-1.03↑25.9%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	29	65↑126.2%	74↑13.1%	57↓23.4%	42↓26.3%
Total Current Assets	30	67↑120.3%	76↑14.4%	59↓22.8%	45↓23.7%
Total Assets	31	67↑117.5%	77↑14.6%	59↓22.9%	45↓23.6%
Total Current Liabilities	3	4↑14.8%	10↑161.5%	14↑38.8%	17↑25.4%
Total Liabilities	4	4↑6.0%	33↑727.7%	33↑0.8%	26↓20.8%
Total Equity	27	63↑133.0%	44↓30.4%	26↓40.6%	19↓27.3%
Total Debt	1	0↓19.6%	23↑4686.9%	24↑1.6%	22↓8.5%
Net Debt	-28	-65↓129.4%	-50↑22.2%	-33↑35.0%	-20↑39.3%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-13	-12↑5.0%	-26↓105.9%	-34↓30.8%	-35↓4.1%
Capital Expenditure	0	0	0	0	-0
Free Cash Flow	-13	-12↑5.0%	-26↓105.9%	-34↓30.8%	-35↓4.2%
Stock-Based Comp	0	4↑808.8%	5↑26.4%	8↑46.5%	7↓10.1%
Net Change in Cash	17	36↑118.3%	9↓76.4%	-17↓301.2%	-15↑13.8%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance